Patents by Inventor Luis Pardo-Fernandez

Luis Pardo-Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human K channel and prognosing applications thereof
    Patent number: 7364730
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: April 29, 2008
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Human Kchannel and prognosing applications thereof
    Patent number: 7364845
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: April 29, 2008
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Antibodies to a human Kchannel and therapeutic applications thereof
    Publication number: 20080020406
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Application
    Filed: November 30, 2006
    Publication date: January 24, 2008
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Luis Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Human Kchannel polypeptides
    Patent number: 7314914
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: January 1, 2008
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften, E.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh
  • Human K ion channel and therapeutic applications thereof
    Patent number: 7129207
    Abstract: The present invention relates to a novel human K+ ion channel, to nucleic acid molecules encoding the same and to vectors comprising said nucleic acid molecules. The invention additionally relates to antibodies specifically directed to the novel K+ ion channel and to pharmaceutical compositions and diagnostic kits containing at least one of the above-mentioned components. Furthermore, the present invention relates to methods of treating a disease caused by malfunction of the polypeptide of the present invention or by the (over)expression of the nucleic acid molecule of the invention comprising administering an inhibitor of said (over)expression or of ion channel function or an inhibitor abolishing said malfunction to a patient in need thereof. Methods of devising drugs for treating or preventing the above-mentioned disease, methods of inhibiting cell proliferation and methods of prognosing cancer are additional embodiments comprised by the present invention.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: October 31, 2006
    Assignee: Max-Planck-Gesellschaft zur Forderung Wissenschaften e.V.
    Inventors: Luis A Pardo-Fernandez, Walter Stuhmer, Synnove Beckh, Andrea Bruggemann, Donato Del Camino Fernandez-Miranda, Araceli Sanchez Perez, Rudiger Weseloh